Evidence map›Paper›PMID 20179272›Full record

ArticleScience signaling2010

DNA-PKcs controls an endosomal signaling pathway for a proinflammatory response by natural killer cells.

Sumati Rajagopalan, Mark W Moyle, Irma Joosten, Eric O Long

Abstract read
In one paragraph

Article in Science signaling, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. HLA-G and the MHC Cusp Theory.Frontiers in immunology · 2022
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. The HLA-G cycle provides for both NK tolerance and immunity at the maternal-fetal interface.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sumati RajagopalanLaboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA. sumi@nih.gov
Mark W Moyle
Irma Joosten
Eric O Long
National Institute of Allergy and Infectious Diseases · USNational Institutes of Health · US

Funding

Natural Killer Cells in PregnancyZIAAI001119 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI LONG, ERIC O · 2009 to 2025
$4.9M
Intramural NIH HHS ZIA AI001119
6 · The paper itself

Abstract

Endosomes are emerging as specialized signaling compartments that endow receptors with distinct signaling properties. The diversity of endosomal signaling pathways and their contribution to various biological responses is still unclear. CD158d, which is also known as the killer cell immunoglobulin-like receptor (KIR) 2DL4 (KIR2DL4), is an endosome-resident receptor in natural killer (NK) cells that stimulates the release of a unique set of proinflammatory and proangiogenic mediators in response to soluble human leukocyte antigen G (HLA-G). Here, we identified the CD158d signaling cascade. In response to soluble agonist antibody or soluble HLA-G, signaling by CD158d was dependent on the activation of nuclear factor kappaB (NF-kappaB) and the serine-threonine kinase Akt. CD158d associated with the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs), promoted the recruitment of Akt to endosomes, and stimulated the DNA-PKcs-dependent phosphorylation of Akt. The sequential requirement for DNA-PKcs, Akt, and NF-kappaB in signaling by CD158d delineates a previously uncharacterized endosomal signaling pathway for a proinflammatory response in NK cells.

Indexed as

Cell LineDNA-Activated Protein KinaseElectrophoresis, Polyacrylamide GelEndosomesHistocompatibility Antigens Class IHLA AntigensHLA-G AntigensHumansImmunoprecipitationInflammationKiller Cells, NaturalMass SpectrometryMicroscopy, ConfocalNF-kappa BPhosphorylationProto-Oncogene Proteins c-aktDNA-Activated Protein KinaseHistocompatibility Antigens Class IHLA AntigensHLA-G AntigensKIR2DL4 protein, humanNF-kappa BProto-Oncogene Proteins c-aktReceptors, KIR2DL4

Identifiers

PMID20179272
PMCPMC4793721
OpenAlexW1984878605

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.